Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 159.40
Bid: 159.20
Ask: 160.00
Change: 0.20 (0.13%)
Spread: 0.80 (0.503%)
Open: 159.20
High: 159.40
Low: 158.80
Prev. Close: 159.20
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

3 Jun 2020 07:00

RNS Number : 7409O
Forterra plc
03 June 2020
 

Forterra plc

 

3 June 2020 

 

 Trading Update

 

Forterra plc, a leading UK producer of manufactured masonry products, provides this update and further detail on the measures it is taking to mitigate the impact of Covid-19.

 

Trading and operational update

 

Since our announcement of 28 April 2020, we have been encouraged by a gradual increase in despatches as our customers reopened their operations. Daily despatches of our brick & block products have now recovered to approximately 50% of corresponding 2019 levels. Group revenue declined by 39% for the five months to 31 May 2020 compared with the corresponding period in 2019, with a year-on-year decline of 86% in April and 62% in May.

 

We are currently manufacturing at twelve of our eighteen facilities and are preparing to further increase production as demand requires. We anticipate recommencing production at most of our remaining facilities by the end of July and retain full flexibility to reopen facilities sooner should demand increase at a faster rate than expected.

 

Restructuring

 

Economic and industry forecasts indicate a prolonged impact from Covid-19 on the UK economy and more specifically the construction sector. Although the Construction Products Association's most recent forecast anticipates the residential construction market will recover during 2021, output in 2021 is forecast to be approximately 20% lower than in 2019.

 

Accordingly, we are taking steps to restructure the Group's operations in line with the anticipated decline in medium-term demand. In the coming weeks we will consult with employees on our plans, which include proposed changes to shift patterns and adjustments to the size and structure of support functions. Additionally, these proposals include consolidating the manufacture of all precast concrete flooring products at our Hoveringham facility in Nottinghamshire. This proposal will necessitate the mothballing of our hollowcore flooring manufacturing facility at Swadlincote in Derbyshire once the current order book is completed. These proposals will not affect our ability to service key customers or our specialist precast concrete facility at Swadlincote. These actions, if implemented, will regrettably lead to the loss of approximately 225 jobs, primarily from our concrete products facilities.

 

Balance sheet and liquidity

The Group entered the Covid-19 crisis with net debt (pre IFRS 16) of £43.2m at 31 December 2019. 

The Group has access to a £150m revolving credit facility which runs to July 2022, which is presently fully drawn. At 31 May 2020 the Group had cash reserves of £79m as well as access to an undrawn overdraft facility of £10m.

In addition, Forterra plc has been confirmed as eligible for the joint HM Treasury and Bank of England Covid Corporate Financing Facility (CCFF) with an issuer limit of £175 million and is now able to access the liquidity available under this facility. The Board does not have any present intention to draw upon this facility, which provides the Group with additional headroom if required.

Summary

Despite the economic circumstances created by Covid-19, the Board remains confident that the Group is well positioned to take advantage of the attractive long-term market fundamentals in order to continue delivering sustainable shareholder value. 

Enquiries:

Forterra plc:

+44 (0) 1604 707 600

Stephen Harrison (CEO) / Ben Guyatt (CFO)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain / Nick Hasell

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) prior to its release as part of this announcement.

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBRGDLGBGDGGD
Date   Source Headline
21st Sep 20218:11 amRNSHolding(s) in Company
17th Sep 202111:21 amRNSDirector Declaration
3rd Sep 20213:22 pmRNSEmployee Benefit Trust Share Purchase
27th Aug 20212:58 pmRNSDirector/PDMR Shareholding
27th Aug 202111:15 amRNSDirector Declaration
26th Aug 20217:00 amRNSDisposal of Swadlincote site
9th Aug 20219:32 amRNSHolding(s) in Company
3rd Aug 20212:49 pmRNSEmployee Benefit Trust Share Purchase
29th Jul 20217:56 amRNSProgressive publishes new research
29th Jul 20217:00 amRNSHalf-year Report
13th Jul 20216:03 pmRNSDirector/PDMR Shareholding
5th Jul 202111:22 amRNSEmployee Benefit Trust Share Purchase
15th Jun 20219:56 amRNSDirector/PDMR Shareholding
7th Jun 20219:24 amRNSEmployee Benefit Trust Share Purchase
27th May 20213:45 pmRNSDirector/PDMR Shareholding
18th May 20213:45 pmRNSAnnual General Meeting 2021 Results
18th May 202110:28 amRNSProgressive publishes new research
18th May 20217:00 amRNSTrading Statement
6th May 20217:00 amRNSEmployee Benefit Trust Share Purchase
30th Apr 20214:07 pmRNSHolding(s) in Company
30th Apr 20211:11 pmRNSGrant under Performance Share Plan
9th Apr 20213:46 pmRNSDirector/PDMR Shareholding
9th Apr 202110:56 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSAnnual Report 2020 and Notice of AGM 2021
8th Apr 20213:31 pmRNSEmployee Benefit Trust Share Purchase
1st Apr 202110:59 amRNSDirector/PDMR Shareholding
30th Mar 20211:14 pmRNSDirector/PDMR Shareholding
25th Mar 20212:41 pmRNSDirector/PDMR Shareholding
22nd Mar 20213:55 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSDirector/PDMR Shareholding
9th Mar 20217:00 amRNS2020 FULL YEAR RESULTS
4th Mar 20217:24 amRNSHolding(s) in Company
3rd Mar 202110:36 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSEmployee Benefit Trust Share Purchase
17th Feb 20213:16 pmRNSHolding(s) in Company
15th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20212:16 pmRNSDirector/PDMR Shareholding
2nd Feb 20214:17 pmRNSEmployee Benefit Trust Share Purchase
1st Feb 20214:48 pmRNSDirector/PDMR Shareholding
28th Jan 202112:38 pmRNSHolding(s) in Company
27th Jan 20213:40 pmRNSHolding(s) in Company
26th Jan 20218:15 amRNSProgressive publishes new research
26th Jan 20217:00 amRNSTrading Statement
6th Jan 20217:21 amRNSEmployee Benefit Trust Share Purchase
6th Jan 20217:21 amRNSDirector/PDMR Shareholding
4th Jan 20219:29 amRNSHolding(s) in Company
8th Dec 20202:28 pmRNSEmployee Benefit Trust Share Purchase
27th Nov 20207:00 amRNSEmployee Benefit Trust Share Purchase
24th Nov 20201:00 pmRNSEmployee Benefit Trust Share Purchase
24th Nov 20208:24 amRNSProgressive publishes new research

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.